Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232958 · ClinicalTrials.gov registry record · NA
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
A NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02232958: Clinical Trial NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
NCT02232958 is a NA study that was terminated before completion, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02232958, a NA study, was terminated before completion, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to extend our previous work, in which we demonstrated an increase in the internal and cross network connectivity of resting state neural networks in patients with cerebral small vessel disease by treatment with hyperbaric oxygen, to at least 20 more individuals.
Primary Outcome
Patients with small vessel disease of the brain will be treated with 10 hyperbaric oxygen sessions for 1 hour at 2 atmospheres absolute over the course of 2 weeks. Functional connectivity MRIs will be obtained 4-6 weeks after these sessions for comparison with those obtained before hyperbaric oxygen exposure
Interventions
- OTHER Hyperbaric Oxygen Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-09-16 |
| Est. Completion | 2017-10-04 |
| Phase | NA |
Why NCT02232958 stopped before completion
NCT02232958 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Treatment is the first listed.
NCT02232958 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02232958 about?
NCT02232958 is a clinical study titled "Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease". The purpose of this study is to extend our previous work, in which we demonstrated an increase in the internal and cross network connectivity of resting state neural networks in patients with cerebral small vessel disease by treatment with hyperbaric oxygen, to at least 20 more individuals.
What is the current status of trial NCT02232958?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2014-09-16. Estimated completion is 2017-10-04.
What interventions are being tested in trial NCT02232958?
The interventions under investigation include: Hyperbaric Oxygen Treatment (OTHER).
Who is sponsoring clinical trial NCT02232958?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02232958's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI